A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease

An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

NCT00939783 ·Status: TERMINATED ·Phase: PHASE3

Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil

NCT00829816 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin

NCT00990613 ·Status: COMPLETED ·Phase: PHASE1

An Extension of the CONCERT Protocol (DIM18)

NCT01152216 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia

NCT07251023 ·Status: RECRUITING ·Phase: PHASE3

A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease

NCT01066481 ·Status: WITHDRAWN ·Phase: PHASE2

Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease

NCT00377715 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects

NCT00825084 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

NCT00824590 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease

NCT00675623 ·Status: COMPLETED ·Phase: PHASE3

A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)

NCT03114657 ·Status: TERMINATED ·Phase: PHASE3

Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease

NCT00704782 ·Status: TERMINATED ·Phase: PHASE2

A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

NCT00827034 ·Status: COMPLETED ·Phase: PHASE1

An Open-Label Crenezumab Study in Participants With Alzheimer's Disease

NCT03491150 ·Status: TERMINATED ·Phase: PHASE3

Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects

NCT04251182 ·Status: COMPLETED ·Phase: PHASE2

Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)

NCT01181310 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

NCT00454870 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

NCT04592874 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease

NCT05478031 ·Status: TERMINATED ·Phase: PHASE2

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

NCT00895895 ·Status: TERMINATED ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

NCT01009255 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease

NCT03790982 ·Status: UNKNOWN ·Phase: PHASE2

Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

NCT01266525 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease

NCT03625401 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

NCT04971733 ·Status: COMPLETED ·Phase: PHASE1/PHASE2